Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome

Clinical Obstetrics and Gynecology

Volumn 54, Issue 4, 2011, Pages 685-695

  Casper, Robert F ^a,b,c   Mitwally, Mohamed F M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Toronto Centre for Advanced Reproductive Technology   (Canada)

Author keywords

letrozole; ovulation induction; polycystic ovarian syndrome

Indexed keywords

ANASTROZOLE; CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE;

AMENORRHEA; ANENCEPHALUS; AORTA COARCTATION; ARTICLE; BIRTH DEFECT; BLURRED VISION; BREAST CANCER; BREAST TENDERNESS; CRANIOFACIAL SYNOSTOSIS; DANDY WALKER SYNDROME; DEPRESSION; DIPLOPIA; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; ECTOPIC PREGNANCY; EMBRYO DEVELOPMENT; ESOPHAGUS ATRESIA; ESTROGEN BLOOD LEVEL; FEMALE INFERTILITY; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HEART VENTRICLE SEPTUM DEFECT; HOT FLUSH; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRAUTERINE INSEMINATION; IRRITABILITY; MATERNAL AGE; MULTIPLE PREGNANCY; NAUSEA; NEGATIVE FEEDBACK; OLIGOMENORRHEA; OMPHALOCELE; OPTIMAL DRUG DOSE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PELVIS PAIN SYNDROME; PREGNANCY OUTCOME; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; TERATOGENICITY; TREATMENT OUTCOME; TWIN PREGNANCY; VISUAL FIELD DEFECT;

ANOVULATION; AROMATASE INHIBITORS; CLOMIPHENE; CONGENITAL ABNORMALITIES; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; NITRILES; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; TRIAZOLES;

EID: 80055068439     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182353d0f     Document Type: Article

References (36)

1. Payne S, Karow WG. The use of clomiphene in the treatment of infertility due to ovarian dysfunction. West J Surg Obstet Gynecol. 1963;71:262-265.
2. Roy S, Greenblatt RB, Mahesh VB, et al. Clomiphene citrate: further observations on its use in induction of ovulation in human and its mode of action. Fertil Steril. 1963;14:575-595.
3. Young SL, Opsahl MS, Fritz MA. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril. 1999;7: 639-644. (Pubitemid 29149412)
4. Adashi EY. Clomiphene citrate: mechanism( s) and site(s) of action: a hypothesis revisited. Fertil Steril. 1984;42: 331-344.
5. Zhuang LZ, Adashi EY, Hsueh AJ. Direct enhancement of gonadotropinstimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology. 1982;110:2219-2221.
6. Fisher SA, Reid RL, Van Vugt DA, et al. A randomized double blind comparison of the effects of clomiphene citrate and the AI letrozole on ovulatory function in normal women. Fertil Steril. 2002;78: 280-285. (Pubitemid 34845895)
7. Casper RF. Letrozole: Ovulation or superovulation? Fertil Steril. 2003;80: 1335-1337. (Pubitemid 37532443)
8. Garcia J, Seegar Jones G, Wentz AC. The use of clomiphene citrate. Fertil Steril. 1977;28:707-717. (Pubitemid 8149574)
9. Rebecca S. Usadi and Marc A. Fritz. Induction of Ovulation with clomiphene citrate. Sciarra. (Ed.) Obstetrics and Gynecology, Chapter 68.
10. Purvin V. Visual disturbance secondary to clomiphene citrate. Arch Ophthalmol. 1995;113:482.
11. Bateman BG, Nunley WC, Kolp LA. Exogenous estrogen therapy for treatment of clomiphene citrate-induced cervical mucus abnormalities: is it effective? Fertil Steril. 1990;54:577.
12. Ben-Ami M, Geslevich Y, Matilsky M, et al. Exogenous estrogen therapy concurrent with clomiphene citrate: lack of effect on serum sex hormones and endometrial thickness. Gynecol Obstet Invest. 1994;37:180-182. (Pubitemid 24089924)
13. Gonen Y, Casper RF. Sonographic Determination of an Adverse Effect of Clomiphene Citrate on Endometrial Growth. Hum Reprod. 1990;5: 670-674. (Pubitemid 20308440)
14. Nelson LM, Hershlag A, Kurl RS, et al. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril. 1990;53:727-731. (Pubitemid 20143060)
15. Li TC, Warren MA, Murphy C, et al. A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal fertile women. Br J Obstet Gynaecol. 1992;99:1008-1013.
16. Massai MR, de Ziegler D, Lesobre V, et al. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril. 1993;59: 1179-1186. (Pubitemid 23163188)
17. Schenker JG, Jarkoni S, Granat M. Multiple pregnancies following induction of ovulation. Fertil Steril. 1981; 35:105.
18. Magnus O, Tanbo T, Henriksen T, et al. Severe ovarian hyperstimulation syndrome: case reports. Acta Eur Fertil. 1988;19:89-92. (Pubitemid 19007432)
19. Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility and Sterility. 2006;85: 1761-1765. (Pubitemid 43816444)
20. Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem. 1990;33: 2933-2944.
21. Santen RJ, Manni A, Harvey H, et al. Endocrine treatment of breast cancer in women. Endocrine Rev. 1990;11:1-45.
22. Mitwally MF, Casper RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovary syndrome. Reprod Technol. 2000;10: 244-247.
23. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in cases of inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305-309. (Pubitemid 32112106)
24. Polyzos NP, Tzioras S, Badawy AM, et al. Aromatase inhibitors for female infertility: a systematic review of the literature. Reprod Biomed Online. 2009;19: 456-471.
25. Abdellah MS. Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet. 2011;31.
26. Garcia-Velasco JA, Moreno L, Pacheco A, et al. The AI letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril. 2005;84: 82-87. (Pubitemid 40991464)
27. Al-Fozan H, Al-Khadouri M, Tan SL, et al. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82:1561-1563. (Pubitemid 39611383)
28. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril. 2005;83:229-231. (Pubitemid 40094811)
29. Mitwally MF, Said T, Galal A, et al. Letrozole Step-Up Protocol: a Successful Superovulation Protocol. Fertil Steril, 2008; 89, SUPPL.ement 1, S23-S24.
30. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002;2015: 3317-3327. (Pubitemid 34831529)
31. Garcia-Velasco JA, Moreno L, Pacheco A, et al. The AI letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril. 2005;84:82-87. (Pubitemid 40991464)
32. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an AI for induction of ovulation. Am J Obstet Gynecol. 2005;192:381-386. (Pubitemid 40214968)
33. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril. 2005;84 (SUPPL. 1):S95.
34. Reefhuis J, Honein MA, Schieve LAand The National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. Hum Reprod. 2011;451-457.
35. Forman R, Gill S, Moretti M, et al. Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynaecol Can. 2007;29:668-671.
36. Bedaiwy MA, Forman R, Mousa NA, et al. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Hum Reprod. 2006;21: 2838-2844. (Pubitemid 44566995)